The elevated expression of CXCR4 on AML cells is associated with decreased patient survival [16], and attempts have been made to mobilize leukemic cells out of the protective niche of the BMME using CXCR4 inhibitors such as plerixafor. Here, CXCR4 is linked to acute myeloid leukemia.